Human Microbiome Market is anticipated to grow at a CAGR of 7.1% by 2028 | TMR Study

Human Microbiome Market
Rise in venture capital investments, and the surge in the financing of the microbiome projects is projected to drive the global market during the period
WILMINGTON, DELAWARE, UNITED STATES, October 27, 2023 /EINPresswire.com/ -- Human Microbiome Market has seen significant growth over the past few years and is expected to continue expanding rapidly through 2028. According to recent reports, the global market was valued at USD 1.3 billion in 2020. It is projected to grow at a compound annual growth rate of 7.1% between 2021 and 2028. This strong growth will be driven by rising awareness of the important role our microbiomes play in health and disease, as well as increasing research and development activities in microbiome-based therapies. If the market continues on its current trajectory, it is estimated that the global human microbiome industry will reach a value of USD 2.2 billion by the end of 2028.The human microbiome refers to the trillions of microorganisms, including bacteria, fungi and viruses, that live symbiotically in and on our bodies. Scientists have increasingly shown that the microbiome plays a key role in human health and disease.
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐ฎ ๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐ผ๐ณ ๐๐ต๐ถ๐ ๐ฃ๐ฟ๐ฒ๐บ๐ถ๐๐บ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3999
The human microbiome refers to the microorganisms that live in and on the human body, such as bacteria, fungi, viruses and more. There is growing research showing that the microbiome plays a key role in human health and disease. As understanding of the microbiome's impact has increased, it has opened up opportunities for microbiome-based diagnostics, therapeutics and other products and services.
Some of the key factors driving market growth include rising incidence of chronic diseases linked to microbiome imbalances, increasing R&D investments in microbiome science from pharmaceutical and biotech companies, and growing awareness among consumers and healthcare providers of the microbiome's importance. The report finds probiotics supplements will continue to be the largest revenue-generating product segment, but notes diagnostics and therapeutics segments are expected to see the most rapid growth over the coming years.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป
๐๐ป๐ฑ๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป
Gastrointestinal & Metabolic Disorders
Womenโs Health
Cancer
Others
๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐
16s rRNA Sequencing
Metagenomic Sequencing
๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ ๐๐ฟ๐ฒ๐ฎ
Gastrointestinal Disorders
Metabolic Disorders
Womenโs Health
Skin Disorders
Others
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=3999
๐๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด ๐ฝ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐ผ๐ฝ๐ฒ๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐ถ๐ป ๐๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ต๐๐บ๐ฎ๐ป ๐บ๐ถ๐ฐ๐ฟ๐ผ๐ฏ๐ถ๐ผ๐บ๐ฒ ๐ถ๐ป๐ฑ๐๐๐๐ฟ๐ ๐ฎ๐ฟ๐ฒ
AOBiome
Enterome Biosciences SA
Metabiomics Corp. (BioSpherex LLC)
Microbiome Therapeutics LLC
Osel, Inc.
Rebiotix, Inc.
Second Genome
Seres Therapeutics
Synthetic Biologics, Inc.
Vedanta Biosciences
4D Pharma
๐๐๐บ๐ฎ๐ป ๐ ๐ถ๐ฐ๐ฟ๐ผ๐ฏ๐ถ๐ผ๐บ๐ฒ ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ - ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐:
The value chain analysis, ecosystem analysis, and regulatory scenario are added in the market overview chapter.
The new edition of the report provides updated market breakdown with detailed analysis on product, type, application and disease.
The new edition of the report provides updated financial information till 2023 (depending on availability) for each listed company in a graphical representation. This would help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.
Recent developments are helpful to understand market trends and growth strategies adopted by players in the market.
Tracking product portfolios of prominent market players helps to analyze the major types in the human microbiome market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.
Market evaluation framework, market share analysis and competitive leadership mapping have been added in competitive landscape chapter of the report.
The competitive leadership mapping has been updated considering recent developments in the company evaluation matrix.
๐๐ฎ๐๐ฒ ๐๐ป๐ ๐ค๐๐ฒ๐ฟ๐? ๐๐๐ธ ๐ข๐๐ฟ ๐๐ ๐ฝ๐ฒ๐ฟ๐๐ https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=3999
๐๐ฒ๐ ๐พ๐๐ฒ๐๐๐ถ๐ผ๐ป๐ ๐ฎ๐ป๐๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ถ๐ป ๐๐๐บ๐ฎ๐ป ๐ ๐ถ๐ฐ๐ฟ๐ผ๐ฏ๐ถ๐ผ๐บ๐ฒ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐:
What is the current market size for products and services related to the human microbiome?
What is the projected growth rate of the Human Microbiome Market in the near future?
What are the different product categories and applications within the Human Microbiome Market?
How are these segments performing in terms of market share and growth?
Who are the major companies and research institutions operating in the Human Microbiome Market?
How do regulatory factors impact market entry and growth?
How do these advancements impact the market?
What are the primary factors driving the interest and investment in the Human Microbiome Market?
What are the challenges and barriers faced by companies and researchers in the Human Microbiome Market?
What are the future prospects for the Human Microbiome Market?
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก-
DNA Repair Drugs Market
Increase in usage of DNA repair drugs as a combination therapy for improving treatment outcomes in ovarian and breast cancer is anticipated to propel the DNA Repair Drugs market. Considerable R&D activities in poly (ADP-ribose) polymerase (PARP) inhibitor combination therapy presents significant revenue opportunities for companies in the market
Wearable Neurorehabilitation Devices Market
Increase in usage of wearable devices for neurorehabilitation in stroke patients is anticipated to drive market development. The market in North America is witnessing significant growth opportunities due to presence of several prominent companies and rise in incidence of strokes and Parkinsonโs diseases in the region
Nikhil Sawlani
Transparency Market Research Inc.
+ +1 518-618-1030
email us here
Visit us on social media:
Twitter
LinkedIn
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.